{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:21:10Z","timestamp":1792574470576,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic and Interventional Imaging"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.diii.2023.12.006","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T13:08:52Z","timestamp":1703941732000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: A six-month outcome analysis in 103 patients"],"prefix":"10.1016","volume":"105","author":[{"given":"Romaric","family":"Loffroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5639-5712","authenticated-orcid":false,"given":"Alexis","family":"Quirantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e9vin","family":"Guillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8597-8062","authenticated-orcid":false,"given":"Amin","family":"Mazit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6651-2784","authenticated-orcid":false,"given":"Pierre-Olivier","family":"Comby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-8644","authenticated-orcid":false,"given":"Ludwig Serge","family":"Aho-Gl\u00e9l\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-3174","authenticated-orcid":false,"given":"Olivier","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diii.2023.12.006_bib0001","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0022-5347(05)00310-1","article-title":"Benign prostatic hyperplasia in primary care: what you need to know","volume":"175","author":"Burnett","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.diii.2023.12.006_bib0002","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ucl.2021.12.003","article-title":"Medical treatment of benign prostatic hyperplasia","volume":"49","author":"Plochocki","year":"2022","journal-title":"Urol Clin Noth Am"},{"key":"10.1016\/j.diii.2023.12.006_bib0003","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/JU.0000000000001298","article-title":"Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020","volume":"204","author":"Parsons","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.diii.2023.12.006_bib0004","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.crad.2019.12.019","article-title":"The relationship of embolic particle size to patient outcomes in prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-regression","volume":"75","author":"Geevarghese","year":"2020","journal-title":"Clin Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0005","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s00270-018-1912-5","article-title":"Factors predicting a good symptomatic outcome after prostate artery embolisation","volume":"41","author":"Maclean","year":"2018","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bju.13147","article-title":"Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates","volume":"117","author":"Wang","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.diii.2023.12.006_bib0007","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.euf.2018.09.005","article-title":"Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"5","author":"Zumstein","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.diii.2023.12.006_bib0008","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.urology.2015.04.037","article-title":"Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities","volume":"86","author":"Russo","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.diii.2023.12.006_bib0009","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00270-015-1202-4","article-title":"Transurethral resection of the prostate versus original and PErFecTED prostate artery embolization due to benign prostatic hyperplasia: preliminary results of a single center, prospective, urodynamic-controlled analysis","volume":"39","author":"Carnevale","year":"2016","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1051-0443(07)61638-8","article-title":"Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization","volume":"11","author":"DeMeritt","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0011","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.diii.2022.07.002","article-title":"Efficacy and safety of prostate artery embolization for patients with lower urinary tract symptoms and indwelling urinary catheter: a retrospective multicenter study","volume":"103","author":"Frandon","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2023.12.006_bib0012","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diii.2023.01.012","article-title":"Long-term outcomes of prostate artery embolization for acute urinary retention: an analysis of 88 patients","volume":"104","author":"Marchi","year":"2023","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2023.12.006_bib0013","doi-asserted-by":"crossref","first-page":"k2338","DOI":"10.1136\/bmj.k2338","article-title":"Comparison of prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: randomised, open label, non-inferiority trial","volume":"361","author":"Abt","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.diii.2023.12.006_bib0014","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/bju.14249","article-title":"Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study)","volume":"122","author":"Ray","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.diii.2023.12.006_bib0015","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1148\/radiol.2020191249","article-title":"Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years\u2019 experience","volume":"296","author":"Carnevale","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2023.12.006_bib0016","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1148\/radiol.2016152292","article-title":"Predictors of clinical outcome after prostate artery embolization with spherical and non spherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia","volume":"281","author":"Bilhim","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2023.12.006_bib0017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00261-017-1267-4","article-title":"Safety and efficacy of transcatheter embolization with Glubran\u00ae2 cyanoacrylate glue for acute arterial bleeding: a single-center experience with 104 patients","volume":"43","author":"Abdulmalak","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0018","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s00330-020-07427-y","article-title":"Ten-year experience with arterial embolization for peptic ulcer bleeding: n-butyl cyanoacrylate glue versus other embolic agents","volume":"31","author":"Loffroy","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0019","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/157016109787455617","article-title":"Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues","volume":"7","author":"Loffroy","year":"2009","journal-title":"Curr Vasc Pharm"},{"key":"10.1016\/j.diii.2023.12.006_bib0020","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.3390\/jcm10143161","article-title":"Prostate artery embolization using n-butyl cyanoacrylate glue for urinary tract symptoms due to benign prostatic hyperplasia: a valid alternative to microparticles\u202f?","volume":"10","author":"Loffroy","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.diii.2023.12.006_bib0021","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00270-022-03069-3","article-title":"Prostatic artery embolization for benign prostatic obstruction: single-center retrospective study comparing microspheres versus n-butyl cyanoacrylate","volume":"45","author":"Salet","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvir.2020.100695","article-title":"Prostate artery embolization: state of the evidence and societal guidelines","volume":"23","author":"Young","year":"2020","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0023","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)66780-6","article-title":"Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?","volume":"154","author":"Barry","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.diii.2023.12.006_bib0024","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diii.2023.12.006_bib0025","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","article-title":"Society of Interventional Radiology clinical practice guidelines","volume":"14","author":"Sacks","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0026","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jvir.2017.06.019","article-title":"Proposal of a new adverse event classification by the Society of Interventional Radiology standards of practice committee","volume":"28","author":"Khalilzadeh","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0027","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.urology.2019.11.003","article-title":"Prostatic artery embolization in non-index benign prostatic hyperplasia patients: single-center outcomes for urinary retention and gross prostatic hematuria","volume":"136","author":"Ayyagari","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.diii.2023.12.006_bib0028","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.diii.2023.12.006_bib0029","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.diii.2022.09.007","article-title":"How to report and compare quantitative variables in a radiology article","volume":"103","author":"Barat","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2023.12.006_bib0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00330-018-5564-2","article-title":"Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"29","author":"Malling","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0031","doi-asserted-by":"crossref","unstructured":"Loffroy R. Glubran2\u00ae, Histoacryl\u00ae or Trufill\u00ae: Which cyanoacrylate glue for endovascular use? Diagn Interv Imaging 2016;97:119.","DOI":"10.1016\/j.diii.2015.04.011"},{"key":"10.1016\/j.diii.2023.12.006_bib0032","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00270-016-1539-3","article-title":"A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia","volume":"40","author":"Kuang","year":"2017","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0033","article-title":"Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care","volume":"23","author":"Blanker","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.diii.2023.12.006_bib0034","article-title":"Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"12","author":"Jung","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.diii.2023.12.006_bib0035","article-title":"Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis","volume":"15","author":"Franco","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.diii.2023.12.006_bib0036","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.crad.2016.10.009","article-title":"Systematic review and meta-analysis of prostatic artery embolisation for lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"72","author":"Pyo","year":"2017","journal-title":"Clin Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0037","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4081\/aiua.2018.1.40","article-title":"The impact of prostate artery embolization on the physical history and pathophysiology of benign prostatic hyperplasia","volume":"90","author":"Stamatiou","year":"2018","journal-title":"Arch Ital Urol"},{"key":"10.1016\/j.diii.2023.12.006_bib0038","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jmbbm.2017.01.003","article-title":"Polymerization kinetics of n-butyl cyanoacrylate glues used for vascular embolization","volume":"69","author":"Li","year":"2017","journal-title":"J Mech Behav Biomed Mater"},{"key":"10.1016\/j.diii.2023.12.006_bib0039","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jmbbm.2017.05.023","article-title":"Polymerization kinetics of a mixture of Lipiodol and Glubran 2 cyanoacrylate glue upon contact with a protein aceous solution","volume":"74","author":"Li","year":"2017","journal-title":"J Mech Behav Biomed Mater"},{"key":"10.1016\/j.diii.2023.12.006_bib0040","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00270-010-9863-5","article-title":"Comparison of hemostatic durability between N-butyl cyanoacrylate and gelatin sponge particles in transcatheter arterial embolization for acute arterial hemorrhage in a coagulopathic sondition in a swine model","volume":"33","author":"Yonemitsu","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2023.12.006_bib0041","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.diii.2014.03.008","article-title":"Current role of transcatheter arterial embolization for bladder and prostate hemorrhage","volume":"95","author":"Loffroy","year":"2014","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2023.12.006_bib0042","first-page":"261","article-title":"N-butyl cyanoacrylate glue versus nonspherical polyvinyl alcohol particles for prostatic arterial embolization to treat benign prostatic hyperplasia: safety and efficacy","volume":"20","author":"Hijazi","year":"2023","journal-title":"Urol J"},{"key":"10.1016\/j.diii.2023.12.006_bib0043","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diii.2021.01.005","article-title":"Prostate artery embolization for benign prostatic hyperplasia: the hunt for the ideal patient population","volume":"102","author":"Young","year":"2021","journal-title":"Diagn Interv Imaging"}],"container-title":["Diagnostic and Interventional Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568423002425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568423002425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T02:47:21Z","timestamp":1744512441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211568423002425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2211568423002425"],"URL":"https:\/\/doi.org\/10.1016\/j.diii.2023.12.006","relation":{},"ISSN":["2211-5684"],"issn-type":[{"value":"2211-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: A six-month outcome analysis in 103 patients","name":"articletitle","label":"Article Title"},{"value":"Diagnostic and Interventional Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diii.2023.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de radiologie. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}